Brand Reference: Desyrel
| Metric | Verified Benchmark | Source |
|---|---|---|
| Trazodone Hydrochloride (Low-Dose Hypnotic Architecture) RxNorm Concept ID | 10737 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $0.0310 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $22.00 / mo | CMS NADAC + U.S. Retail Markup Index |
| Mark Cuban Cost Plus Wholesale Price | $4.90 / mo | Cost Plus Drugs Wholesale Feed |
| Community Mean Out-of-Pocket Paid | $5.90 / mo | 54 Zero-PHI Verified Patient Logs |
At low nocturnal doses (25–100 mg), saturates cortical 5-HT2A, vascular alpha-1, and tuberomammillary H1 receptors without reaching the 150–300 mg SERT-inhibition threshold—expanding N3 delta slow-wave deep sleep duration without suppressing REM or causing Z-drug amnesia.
Across 54 community cost disclosures for Trazodone Hydrochloride (Low-Dose Hypnotic Architecture) (Desyrel), cash buyers routing around $22.00 retail markups capture a 78% discount ($4.90/mo benchmark vs $0.0310 NADAC acquisition).
Following administration (25 mg PO QHS), Trazodone Hydrochloride (Low-Dose Hypnotic Architecture) achieves 65%–80% oral (take after light snack to smooth Cmax dizziness) bioavailability and 30–60 minutes bedtime sleep initiation onset, governed by a 5–9 hours biphasic terminal half-life through hepatic cyp3a4 cleavage to m-chlorophenylpiperazine (mcpp, cleared via cyp2d6).
Before initiating Trazodone Hydrochloride (Low-Dose Hypnotic Architecture) at 25 mg PO QHS, clinical safety checklists rule out maoi within 14 days; history of priapism or sickle-cell vaso-occlusion; saquinavir/ritonavir. Logged tolerability patterns center on nasal congestion overnight (23% of reports), morning grogginess if <7h window (21% of reports), orthostatic dizziness (11% of reports).
Across 54 verified cash-pay logs, Trazodone Hydrochloride (Low-Dose Hypnotic Architecture) achieves a 85.80% Worth-It rating with out-of-pocket spend averaging $5.90/mo versus $22.00/mo walk-in retail.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Switched to Cost Plus Drugs at 25 mg PO QHS for Trazodone Hydrochloride (Low-Dose Hypnotic Architecture); monthly out-of-pocket dropped to $4.50 compared with $22.00 retail.
Completed 10 weeks on Trazodone Hydrochloride (Low-Dose Hypnotic Architecture) (50 mg PO QHS). Zero notable side effects on steady dosing.
Consistent biomarker response on 100 mg PO QHS Trazodone Hydrochloride (Low-Dose Hypnotic Architecture) sourced via Cash Clinic ($5.68/mo cash pay without insurance prior authorization).